EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) WATERTOWN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing…
EyePoint Pharmaceuticals stock sinks following clinical trial results By Investing.com EyePoint Pharmaceuticals stock sinks following clinical trial results…
EyePoint Pharmaceuticals: Mit DURAVYU könnte man 40 % der Marktanteile im wAMD-Segment gewinnen! EyePoint Pharmaceuticals Inc. (EYPT) hat sich auf Therapien zur Behandlung schwerer Netzhauterkrankungen spezialisiert. Im Fokus stehen zum Beispiel Lösungen für…
EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering WATERTOWN, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing…
EyePoint Pharmaceuticals (EYPT) Soars 27.6%: Is Further Upside Left in the Stock? EyePoint Pharmaceuticals (EYPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing…
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences WATERTOWN, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing…
EyePoint Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference WATERTOWN, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing…
Cormorant Asset Management buys $10.49m in EyePoint Pharmaceuticals shares By Investing.com Cormorant Asset Management buys $10.49m in EyePoint Pharmaceuticals shares…
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) WATERTOWN, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing…
Earnings call: EyePoint Pharmaceuticals outlines growth and EYP-1901 progress By Investing.com Earnings call: EyePoint Pharmaceuticals outlines growth and EYP-1901 progress…
EyePoint Pharmaceuticals appoints new Chief Medical Officer By Investing.com EyePoint Pharmaceuticals appoints new Chief Medical Officer…